KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02
Axion Research: 36 Kovera certificates.
The lab's record shows 36 certificates printed for Axion Research, analysed between 10 Mar 2026 and 28 Mar 2026, covering 26 products. Median HPLC purity is 99.94%. Kovera graded 36 as a pass and 0 as a fail.
36
certificates
99.94%
median purity
26
products
0
lab verdict: fail
0
failure rules met
What the record shows
RETRIEVED 2 AUGUST 2026None of the 36 certificates meets our failure rules: no lab fail, no unconfirmed identity, no purity under 95% and no content under 90% of the label. 16 measured more than 110% of the label, which Kovera does not grade as a fail.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
26 AS PRINTEDRetatrutide · 4Cagrilintide · 2GHK-Cu · 2KPV · 2NAD+ · 2Semaglutide · 2TB-500 (Thymosin B4) · 2Tirzepatide · 25-Amino-1MQ · 1AOD-9604 · 1ARA-290 · 1BPC-157 · 1BPC-157/TB-500 · 1CJC-1295 (No DAC)/Ipamorelin · 1DSIP · 1IGF-1 LR3 · 1Ipamorelin · 1MOTS-c · 1Retatrutide/Cagrilintide · 1Selank · 1Semaglutide/Cagrilintide · 1Semax · 1Semax/Selank · 1Semax/Selank/P21 · 1Snap-8 · 1Tesamorelin · 1
Every certificate
NEWEST FIRST · 36 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| KVR-2026-DAEFA5 | Retatrutide | AR-326GLP3RT20 | 99.933% | 118.4%23.68 of 20 mg | 28 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-BBBBDC | Semaglutide | AR-326GLP1S20 | 99.923% | 110.2%22.03 of 20 mg | 28 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-631F0D | Tirzepatide | AR-326GLP2TZ60 | 99.983% | 106.0%63.57 of 60 mg | 28 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-2E8441 | Semaglutide | AR-326GLP1S10 | 99.923% | 106.2%10.62 of 10 mg | 28 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-21CA12 | Retatrutide | AR-326GLP3RT50 | 99.982% | 107.3%53.64 of 50 mg | 28 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-D73B49 | Snap-8 | AR-326SN810 | 99.948% | 105.7%10.57 of 10 mg | 26 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-CC7CDA | ARA-290 | AR-3267Ara29010 | 99.926% | 106.4%10.64 of 10 mg | 26 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-CC29B0 | NAD+ | AR-326Nad500 | 99.983% | 107.5%537.66 of 500 mg | 26 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-B7275B | Semax/Selank/P21 | AR-326SMSKP2115 | 99.884% | 106.2%15.93 of 15 mg | 26 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-9526B4 | Semaglutide/Cagrilintide | AR-326SMCGR5 | 99.796% | 108.4%5.42 of 5 mg | 26 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-8CA5BD | KPV | AR-326Kpv10 | 99.929% | 106.7%10.67 of 10 mg | 26 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-8BF713 | BPC-157 | AR-326BPC5 | 99.963% | 108.2%5.41 of 5 mg | 26 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-6F3E09 | 5-Amino-1MQ | AR-5amino10 | 99.983% | 113.1%11.31 of 10 mg | 26 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-5BF713 | Cagrilintide | AR-326Cagri10 | 99.964% | 105.2%10.52 of 10 mg | 26 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-2F86C2 | GHK-Cu | AR-328GHK100 | 99.931% | 116.8%116.84 of 100 mg | 26 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-215546 | KPV | AR-326kpv5 | 99.931% | 106.2%5.31 of 5 mg | 26 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-042A2E | Selank | AR-326SK10 | 99.931% | 106.2%10.62 of 10 mg | 26 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-D00F0C | Retatrutide | AR-326GLP3RT20 | 99.947% | 112.3%22.47 of 20 mg | 21 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-7B01C7 | NAD+ | AR-326NAD500 | 99.923% | 105.7%528.32 of 500 mg | 21 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-4E3DB6 | Tesamorelin | AR-326TS5 | 99.986% | 118.2%5.91 of 5 mg | 21 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-1BF988 | Semax | AR-326SX10 | 99.972% | 114.8%11.48 of 10 mg | 21 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-4704D6 | AOD-9604 | AR-326AOD5 | 99.943% | 116.6%5.83 of 5 mg | 18 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-3E371B | Ipamorelin | AR-326IPA10 | 99.986% | 108.4%10.84 of 10 mg | 18 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-EEE52F | TB-500 (Thymosin B4) | AR-326TB10 | 99.981% | 108.1%10.81 of 10 mg | 10 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-EDC161 | Retatrutide/Cagrilintide | AR-326RTCG20 | 99.784% | 109.2%21.84 of 20 mg | 10 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-E272B7 | IGF-1 LR3 | AR-326IGF1 | 99.959% | 114.0%1.14 of 1 mg | 10 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-C05674 | Retatrutide | AR-326RT10 | 99.967% | 110.7%11.07 of 10 mg | 10 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-BF42CE | TB-500 (Thymosin B4) | AR-326TB5 | 99.934% | 111.8%5.59 of 5 mg | 10 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-B68A06 | DSIP | AR-326DP10 | 99.924% | 117.7%11.77 of 10 mg | 10 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-AC8352 | CJC-1295 (No DAC)/Ipamorelin | AR-326CJCNDIP10 | 99.756% | 109.0%10.9 of 10 mg | 10 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-9CE0A5 | Cagrilintide | AR-326CGR5 | 99.958% | 121.4%6.07 of 5 mg | 10 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-7FFB3F | Tirzepatide | AR-326TZ10 | 99.983% | 112.2%11.22 of 10 mg | 10 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-549FDA | GHK-Cu | AR-326GHK50 | 99.924% | 105.4%52.71 of 50 mg | 10 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-2B66E5 | BPC-157/TB-500 | AR-326TBBPC10 | 99.852% | 110.1%11.01 of 10 mg | 10 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-1A5AE1 | MOTS-c | AR-326MTC10 | 99.953% | 105.3%10.53 of 10 mg | 10 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-1864CB | Semax/Selank | AR-326SXSK10 | 99.653% | 112.0%11.2 of 10 mg | 10 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |